FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

778562004: Product containing only bumetanide and potassium chloride in oral dose form (medicinal product form)


Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2019. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
3738701012 Bumetanide and potassium chloride only product in oral dose form en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
3738702017 Product containing only bumetanide and potassium chloride in oral dose form (medicinal product form) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


1 descendants. Search Descendants:

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bumetanide and potassium chloride only product in oral dose form Has active ingredient Bumetanide (substance) true Inferred relationship Some 1
Bumetanide and potassium chloride only product in oral dose form Is a Bumetanide and potassium chloride only product true Inferred relationship Some
Bumetanide and potassium chloride only product in oral dose form Is a Bumetanide- and potassium chloride-containing product in oral dose form true Inferred relationship Some
Bumetanide and potassium chloride only product in oral dose form Has active ingredient Potassium chloride true Inferred relationship Some 2
Bumetanide and potassium chloride only product in oral dose form Has manufactured dose form Oral dose form true Inferred relationship Some
Bumetanide and potassium chloride only product in oral dose form Count of base of active ingredient 2 false Inferred relationship Some
Bumetanide and potassium chloride only product in oral dose form Plays role Loop diuretic therapeutic role true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Bumetanide 500 microgram and potassium chloride 573 mg prolonged-release oral tablet Is a True Bumetanide and potassium chloride only product in oral dose form Inferred relationship Some

This concept is not in any reference sets

Back to Start